Inactive Instrument
Asarina Pharma AB Stock
Stocks
ASAP
SE0011641794
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -31.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Nordkild
CEO | Chief Executive Officer | 71 | 2015-12-31 |
| Director of Finance/CFO | 71 | 2017-03-31 | |
Magnus Brisander
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul de Potocki
CHM | Chairman | 64 | 2017-12-31 |
Marianne Kock
BRD | Director/Board Member | 71 | 2017-12-31 |
| Director/Board Member | 52 | 2020-01-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -31.03% | -40.43% | - | - | 64.67K | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -3.22% | -3.79% | +34.48% | +157.35% | 25.98B | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.67% | +119.98% |
Employees
6
